Overview

Evaluating Silymarin for Chronic Hepatitis C

Status:
Completed

Trial end date:
2002-06-01

Target enrollment:
0

Participant gender:

Summary

To investigate the effect of silymarin, derived from the milk thistle plant, Silybum marianum, in preventing and reversing the complications of chronic infection with hepatitis C virus and/or clearing hepatitis C infections.

Phase:

Phase 2

Details

Lead Sponsor:

National Center for Complementary and Integrative Health (NCCIH)

Collaborator:

Office of Dietary Supplements (ODS)

Treatments:

Silymarin